Skip to main content
Top
Published in: Clinical Rheumatology 4/2015

01-04-2015 | Original Article

The COL5A1 gene is associated with increased risk of carpal tunnel syndrome

Authors: Marilize Burger, Hanli de Wet, Malcolm Collins

Published in: Clinical Rheumatology | Issue 4/2015

Login to get access

Abstract

The direct causes of idiopathic carpal tunnel syndrome (CTS), a common upper limb entrapment neuropathy, remain unknown. It is however generally accepted that an increase in pressure within the carpal tunnel structure, which contains nine flexor tendons, causes compression of the median nerve. The involvement of these tendons in the aetiology of CTS cannot be excluded. Variants within the collagen, type V, alpha 1 (COL5A1) gene, which encodes for the α1 chain of type V collagen, an important regulator of fibril assembly in tendons, have previously been associated with Achilles tendinopathy. The aim of this study was to determine whether these COL5A1 variants are also associated with CTS. One hundred and three self-reported coloured participants, with a history of carpal tunnel release surgery (CTS) and 150 matched control (CON) participants without any reported history of CTS symptoms were genotyped for the COL5A1 rs13946 (C/T), rs14774622 (C/T)/rs55748801 (G/A) (W/M where W = CG), rs12722 (C/T) and rs71746744 (−/AGGG) variants. The TT genotype of COL5A1 rs13946 was significantly over-represented (p = 0.007) in the CON (69.3 %) compared to that in the CTS (50.6 %) group. When the combined rs14774622/rs55748801 and rs12722 genotypes were analysed, the WW + CC (41.7 %, p = 0.008) and WW + CT (40.3 %, p = 0.009) genotypes were significantly over- and under-represented in the CON group, respectively, when compared to the CTS group (24.5 % WW + CC, 59.2 % WW + CT). Furthermore, the T-W-C (51.2 %, p < 0.001) and C-W-C (15.9 %, p = 0.005) inferred haplotypes were significantly over- and under-represented in the CON compared to the CTS (34.9 % T-W-C, 26.8 % C-W-C). In conclusion, this is the first study to report that variants within the functional COL5A1 3′-untranslated region are associated with the CTS. Further studies are required to replicate these findings.
Appendix
Available only for authorised users
Literature
1.
go back to reference Atroshi I, Gummesson C, Johnsson R (1999) Prevalence of carpal tunnel syndrome in a general population. JAMA 281:153–158CrossRef Atroshi I, Gummesson C, Johnsson R (1999) Prevalence of carpal tunnel syndrome in a general population. JAMA 281:153–158CrossRef
2.
3.
go back to reference Diao E, Shao F, Liebenberg E et al (2005) Carpal tunnel pressure alters median nerve function in a dose-dependent manner: a rabbit model for carpal tunnel syndrome. J Orthop Res 23:218–223CrossRefPubMed Diao E, Shao F, Liebenberg E et al (2005) Carpal tunnel pressure alters median nerve function in a dose-dependent manner: a rabbit model for carpal tunnel syndrome. J Orthop Res 23:218–223CrossRefPubMed
4.
go back to reference Gelberman RH, Hergenroeder PT, Hargens AR et al (1981) The carpal tunnel syndrome: a study of carpal canal pressures. J Bone Jt Surg 63:380–383 Gelberman RH, Hergenroeder PT, Hargens AR et al (1981) The carpal tunnel syndrome: a study of carpal canal pressures. J Bone Jt Surg 63:380–383
5.
go back to reference Ettema AM, Belohlavek M, Zhao C (2006) High-resolution ultrasound analysis of subsynovial connective tissue in human cadaver carpal tunnel. J Orthop Res 19-21 Ettema AM, Belohlavek M, Zhao C (2006) High-resolution ultrasound analysis of subsynovial connective tissue in human cadaver carpal tunnel. J Orthop Res 19-21
13.
go back to reference Abrahams Y, Laguette M-J, Prince S, Collins M (2013) Polymorphisms within the COL5A1 3′-UTR that alters mRNA structure and the MIR608 gene are associated with Achilles tendinopathy. Ann Hum Genet 77:204–214. doi:10.1111/ahg.12013 CrossRefPubMed Abrahams Y, Laguette M-J, Prince S, Collins M (2013) Polymorphisms within the COL5A1 3′-UTR that alters mRNA structure and the MIR608 gene are associated with Achilles tendinopathy. Ann Hum Genet 77:204–214. doi:10.​1111/​ahg.​12013 CrossRefPubMed
20.
go back to reference Guidelines from the SASHG committee for publication purposes regarding: nomenclature for South African populations. 1. Guidelines from the SASHG committee for publication purposes regarding: nomenclature for South African populations. 1.
21.
23.
go back to reference Raymond M, Rousset F (1995) GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 86:248–249 Raymond M, Rousset F (1995) GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 86:248–249
24.
go back to reference Duncan RD, Epstein MP, Satten GA Case–control haplotype inference (CHAPLIN). Version 1.2. Duncan RD, Epstein MP, Satten GA Case–control haplotype inference (CHAPLIN). Version 1.2.
26.
go back to reference Brown JC, Miller C-J, Posthumus M et al (2011) The COL5A1 gene, ultra-marathon running performance and range of motion. Int. J. Sports Physiol, Perform Brown JC, Miller C-J, Posthumus M et al (2011) The COL5A1 gene, ultra-marathon running performance and range of motion. Int. J. Sports Physiol, Perform
28.
go back to reference Posthumus M, September AV, O’Cuinneagain D et al (2009) The COL5A1 gene is associated with increased risk of anterior cruciate ligament ruptures in female participants. Am J Sport Med 37:2234–40. doi:10.1177/0363546509338266 CrossRef Posthumus M, September AV, O’Cuinneagain D et al (2009) The COL5A1 gene is associated with increased risk of anterior cruciate ligament ruptures in female participants. Am J Sport Med 37:2234–40. doi:10.​1177/​0363546509338266​ CrossRef
Metadata
Title
The COL5A1 gene is associated with increased risk of carpal tunnel syndrome
Authors
Marilize Burger
Hanli de Wet
Malcolm Collins
Publication date
01-04-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 4/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2727-7

Other articles of this Issue 4/2015

Clinical Rheumatology 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine